-
Patient Preference and Adherence
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Clinical utility and patient adherence with ebastine for allergic rhinitis
Review
(1509) Views (367) Full article downloads
Authors: Giorgio Ciprandi
Published Date October 2010
Volume 2010:4 Pages 389 - 395
DOI: http://dx.doi.org/10.2147/PPA.S8186
Giorgio CiprandiDepartment of Internal Medicine, San Martino Hospital, Genoa, Italy
Abstract: Allergic rhinitis (AR) is a high prevalence disease, affecting 10%–20% of the general population. AR is sustained by an IgE-mediated reaction, and by a complex inflammatory network of cells, mediators, and cytokines, becoming chronic when exposure to allergen persists. A Th2-biased immune response is the basis for the allergic inflammation. Histamine plays a relevant role in symptom occurrence. Therefore, antihistamine use represents a cornerstone in AR management. Ebastine, a novel antihistamine, is effective overall in controlling symptoms, and its safety profile is good. Recently, a new formulation has been developed, ie, a fast-dissolving tablet. Several studies have demonstrated its favorable characteristics. In conclusion, ebastine is an effective and well tolerated antihistamine that may be prescribed for the treatment of AR. The fast-dissolving tablet formulation provides a new option which may be particularly convenient for the patient.
Keywords: allergic rhinitis, histamine, antihistamines, ebastine, tablets
Readers of this article also read:
Nitric oxide and coronary vascular endothelium adaptations in hypertension
Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model
Potential antidiabetic and antioxidant activities of Morus indica and Asystasia gangetica in alloxan-induced diabetes mellitus
Treatment of congestion in upper respiratory diseases
Laxative-induced rhabdomyolysis
Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Prevalence of psychiatric disorders and associated risk factors in women during their postpartum period: a major public health problem and global comparison
- 8th Annual Patient Adherence, Communications & Engagement Summit
31 May - 1 June 2011, Hotel Concorde, Berlin
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Health literacy and health seeking behavior among older men in a middle-income nation
- Increasing access to quality health care for the poor: Community perceptions on quality care in Uganda
- Prolonged rupture of membranes in term infants: should all babies be screened?
- Narcissistic rage: The Achilles’ heel of the patient with chronic physical illness




